Millipore Sigma Vibrant Logo

371206 Dkk-1, His•Tag®, Mouse, Recombinant

Dkk-1, His•Tag®, Mouse, Recombinant, consists of amino acids 30-272, fused at the C-terminus to a His•Tag® sequence, and expressed in NS0-dervied mouse myeloma cells.

SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.
View Products on Sigmaaldrich.com
371206
Preis & Verfügbarkeit

Übersicht

Replacement Information

Key Spec Table

Purity
≥95% by SDS-PAGE

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
371206-10UG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Glasflasche 10 μg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewRecombinant, murine Dickkopf related protein-1 (Dkk-1), consisting of amino acids 30-272, fused at the C-terminus to a His•Tag® sequence, and expressed in NS0-dervied mouse myeloma cells. Dkk-1 is a well-documented antagonist of the Wnt signaling pathway. The balance between Dkk-1 inhibition and Wnt signaling is essential for bone formation and homeostasis.
      Catalogue Number371206
      Brand Family Calbiochem®
      References
      ReferencesPinzone, J.J. et al. 2009. Blood 113, 517.
      Li, J. et al. 2006. Bone 36, 754.
      Morvan, F. et al. 2006. J. Bone Miner. Res. 21, 934.
      Niehrs, C. 2006. Oncogene 25, 7469.
      Verani, R. et al. 2006. J. Neurochem. 101, 242.
      Cappuccio, I. et al. 2005. J. Neurosci. 25, 2647.
      Kemp, C. et al. 2005. Dev. Dyn. 233, 1064.
      Adamska, M. et al. 2004. Dev. Biol. 272, 134.
      Bullock, C.M. et al. 2004. Mol. Pharmacol. 65, 582.
      Mao, B. et al. 2002. Nature 417, 664.
      Mao, B. et al. 2001. Nature 411, 321.
      Glinka, A. et al. 1998. Nature 391, 357.
      Product Information
      FormLyophilized
      FormulationLyophilized from 0.2 µm filtered PBS, BSA.
      Quality LevelMQ100
      Applications
      Biological Information
      Biological activityND₅₀: 0.2-1 µg/ml as measured by the inhibition of Wnt-3a-induced alkaline phosphatase production in MC3T3-E1 mouse osteoblastic cells.
      Reduction of Axis-inducing activity: 60-100% reduction (using 1 ng rmDkk-1 per embryo) in the number of secondary axes produced in the presence of 10-20 pg Xwnt-8 mRNA using early Xenopus embryos.
      Purity≥95% by SDS-PAGE
      Physicochemical Information
      ContaminantsEndotoxin: ≤1.0 EU/µg protein
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Regulatory Review
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      371206-10UG 04055977191783

      Documentation

      Dkk-1, His•Tag®, Mouse, Recombinant SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Dkk-1, His•Tag®, Mouse, Recombinant Analysenzertifikate

      TitelChargennummer
      371206

      Literatur

      Übersicht
      Pinzone, J.J. et al. 2009. Blood 113, 517.
      Li, J. et al. 2006. Bone 36, 754.
      Morvan, F. et al. 2006. J. Bone Miner. Res. 21, 934.
      Niehrs, C. 2006. Oncogene 25, 7469.
      Verani, R. et al. 2006. J. Neurochem. 101, 242.
      Cappuccio, I. et al. 2005. J. Neurosci. 25, 2647.
      Kemp, C. et al. 2005. Dev. Dyn. 233, 1064.
      Adamska, M. et al. 2004. Dev. Biol. 272, 134.
      Bullock, C.M. et al. 2004. Mol. Pharmacol. 65, 582.
      Mao, B. et al. 2002. Nature 417, 664.
      Mao, B. et al. 2001. Nature 411, 321.
      Glinka, A. et al. 1998. Nature 391, 357.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision22-June-2011 RFH
      DescriptionRecombinant, murine Dickkopf related protein-1 (Dkk-1), consisting of amino acids 30-272, fused at the C-terminus to a His•Tag® sequence, and expressed in NS0-dervied mouse myeloma cells. Dkk-1 is a well-documented antagonist of the Wnt signaling pathway. The balance between Dkk-1 inhibition and Wnt signaling is essential for bone formation and homeostasis.
      FormLyophilized
      FormulationLyophilized from 0.2 µm filtered PBS, BSA.
      Purity≥95% by SDS-PAGE
      ContaminantsEndotoxin: ≤1.0 EU/µg protein
      Biological activityND₅₀: 0.2-1 µg/ml as measured by the inhibition of Wnt-3a-induced alkaline phosphatase production in MC3T3-E1 mouse osteoblastic cells.
      Reduction of Axis-inducing activity: 60-100% reduction (using 1 ng rmDkk-1 per embryo) in the number of secondary axes produced in the presence of 10-20 pg Xwnt-8 mRNA using early Xenopus embryos.
      SolubilityReconstitute to 100 µg/ml with sterile PBS containing ≥1% human or bovine serum albumin.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Toxicity Regulatory Review
      ReferencesPinzone, J.J. et al. 2009. Blood 113, 517.
      Li, J. et al. 2006. Bone 36, 754.
      Morvan, F. et al. 2006. J. Bone Miner. Res. 21, 934.
      Niehrs, C. 2006. Oncogene 25, 7469.
      Verani, R. et al. 2006. J. Neurochem. 101, 242.
      Cappuccio, I. et al. 2005. J. Neurosci. 25, 2647.
      Kemp, C. et al. 2005. Dev. Dyn. 233, 1064.
      Adamska, M. et al. 2004. Dev. Biol. 272, 134.
      Bullock, C.M. et al. 2004. Mol. Pharmacol. 65, 582.
      Mao, B. et al. 2002. Nature 417, 664.
      Mao, B. et al. 2001. Nature 411, 321.
      Glinka, A. et al. 1998. Nature 391, 357.